Precision for Medicine, Inc., a Chevy Chase, Maryland-based specialized service company providing services and infrastructure to support life science companies as they develop new products, secured $150m in private equity financing.
Backers included Oak Investment Partners, J.H. Whitney and Company along with Precision’s Co-Founders Ethan D. Leder (CEO) and Mark P. Clein (President).
The company intends to use the proceeds for acquisitions and development.
Formed in 2012, Precision for Medicine is building a comprehensive platform of specialized development and commercialization services to support life science companies in speeding approval, reducing costs, and optimizing market launch through innovative solutions and a team of over 130 employees which includes experts in regulatory sciences, clinical development, commercialization, and product strategy.
The company also provides next generation bioservices solutions including biorepository, sample management and cellular products from its biorepository facilities in Frederick and Gaithersburg, MD.